Brexit and life sciences webinar: the impact on product authorisations and exclusivity rights

February 2017

In this webinar, recorded on 14 February 2017, Matthew Royle, Tim Worden and Paul England discuss the issues raised by Brexit for the authorisation of medicinal products and medical devices, and how the available exclusivity rights for these products may be affected.

If you have any questions on this article or would like to propose a subject to be addressed by Synapse please contact us.